Table 2 Disc diffusion diameter for various concentrations of LYZ2, LYZ2-SH3b, and vancomycin
From: LYZ2-SH3b as a novel and efficient enzybiotic against methicillin-resistant Staphylococcus aureus
Disc diffusion diameter (mm) | ||||||
|---|---|---|---|---|---|---|
Compound | MRSA: clinical isolate ST239 | MRSA: ATCC 43,300 | ||||
50 µg/ml | 5 µg/ml | 0.5 µg/ml | 50 µg/ml | 5 µg/ml | 0.5 µg/ml | |
LYZ2 | 11 ± 0.3 | 5 ± 0.4 | 0 | 15 ± 0.2 | 10 ± 0.4 | 0 |
LYZ2-SH3b | 16 ± 0.5 | 10 ± 0.2 | 0 | 19 ± 0.5 | 12 ± 0.3 | 0 |
Vancomycin | 20 ± 0.2 | 14 ± 0.4 | 5 ± 0.3 | 22 ± 0.3 | 18 ± 0.4 | 8 ± 0.3 |